ACERUS PHARMACEUTICALS CORPORATION recorded a security interest over 0 patents to FIRST GENERATION CAPITAL INC., recorded 2023-12-22.
Evidence
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). | Assignor: ACERUS PHARMACEUTICALS CORPORATION | Assignee: FIRST GENERATION CAPITAL INC. | Patents: n/a